Medical Testing Laboratory & Aesthetics Beauty Services was Alps’s largest revenue line in fiscal 2026, bringing in $3.15M of $4.86M (65%).
| Timing of transfer of goods or services [axis] | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|
| Medical Testing Laboratory & Aesthetics Beauty Services | $1.76M | $2.62M | $3.15M |
| Cellular Therapy | $407.44K | $586.44K | $883.02K |
| Sale Of Medicine & Healthcare Product | $8.03K | $10.02K | $731.78K |
| Consultation Fee | $232.17K | $157.47K | $92.33K |
| Total | $2.40M | $3.37M | $4.86M |
Alps brought in $4.86M from its four revenue lines in fiscal 2026, the year ended March 31, 2026. That was up 44.1% from $3.37M in fiscal 2025. Medical Testing Laboratory & Aesthetics Beauty Services was the largest at $3.15M (64.8%), ahead of Cellular Therapy at $883.02K (18.2%) and Sale Of Medicine & Healthcare Product at $731.78K (15.1%). The remaining revenue line, Consultation Fee, brought in $92.33K.
Compared with fiscal 2025, Sale Of Medicine & Healthcare Product grew fastest, up 7,203.2% to $731.78K. Every revenue line above 2% of revenue grew. From fiscal 2024 to 2026, combined revenue from these revenue lines grew from $2.40M to $4.86M, a compound annual growth rate of 42.1%. Medical Testing Laboratory & Aesthetics Beauty Services' share of the total fell from 73.1% to 64.8%.
Medical & Wellness Segments was Alps’s largest segment in fiscal 2026, bringing in $4.50M of $4.86M (93%).
| Segments [axis] | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|
| Medical & Wellness Segments | $2.39M | $3.35M | $4.50M |
| Life Science Segments | $523 | $1.82K | $344.52K |
| All Other Segments | $12.92K | $16.21K | $15.04K |
| Total | $2.40M | $3.37M | $4.86M |
Alps brought in $4.86M from its three segments in fiscal 2026, the year ended March 31, 2026. That was up 44.1% from $3.37M in fiscal 2025. Medical & Wellness Segments was the largest at $4.50M (92.6%), ahead of Life Science Segments at $344.52K (7.1%) and All Other Segments at $15.04K (0.3%).
Compared with fiscal 2025, Life Science Segments grew 18,788.0% to $344.52K and Medical & Wellness Segments grew 34.1% to $4.50M. From fiscal 2024 to 2026, combined revenue from these segments grew from $2.40M to $4.86M, a compound annual growth rate of 42.1%. Medical & Wellness Segments' share of the total fell from 99.4% to 92.6%.
Alps (ALPS) reports its revenue by timing of transfer of goods or services [axis] and by segments [axis]. In fiscal 2026, Medical Testing Laboratory & Aesthetics Beauty Services was its largest revenue line, bringing in $3.15M (64.8% of the total), followed by Cellular Therapy at $883.02K (18.2%).
Medical Testing Laboratory & Aesthetics Beauty Services was Alps' largest revenue line in fiscal 2026, bringing in $3.15M, or 64.8% of the $4.86M total across its four revenue lines.
Medical & Wellness Segments was Alps' largest segment in fiscal 2026, bringing in $4.50M, or 92.6% of the $4.86M total across its three segments.
Among Alps' revenue lines that make up at least 2% of revenue, Sale Of Medicine & Healthcare Product grew fastest in fiscal 2026, up 7,203.2% from $10.02K to $731.78K.
Every figure comes from Alps' annual financial filings, as reported. Each line keeps the name Alps gives it, and years follow its fiscal calendar.
Alps' revenue by timing of transfer of goods or services [axis] goes back to fiscal 2024, with figures through fiscal 2026. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.